Industry Update View All
A New Treatment Era with Daratumumab in Transplant-eligible Newly Diagnosed MM Patients

Multiple myeloma is a clonal plasma cell proliferative disorder that is often diagnosed in individuals aged 65 to 74 years 1 . Notably, the treatment landscape of MM has evolved over the last few years with availability of newer agents and combinati...

Dr. Mohsin RoshanFeb 17, 2025
Are We Doing Our Best to Reduce the Risk of HCC in HBV Patients?

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide. Essentially, persistent hepatitis B virus (HBV) infection is one of the most important risk factors for HCC1. Thus, targeted strategies to mitigate HBV ...

Dr. Roy LauFeb 17, 2025
Improving Somnolence with Once-daily Perampanel Tablet in Epileptic Patients: A Case Report

Case Presentation A 35-year-old male, diagnosed with generalised tonic-clonic seizures (GTCS) in May 2023 following his hospitalization in China for his first seizure attack, consulted Dr. Fung’s clinic due to complaints of somnolence that has...

Dr. Roy LauFeb 17, 2025
FeaturedView All